Generics Global Industry Guide 2017-2021

  • ID: 4472163
  • Report
  • Region: Global
  • 247 pages
  • MarketLine
1 of 3
Generics Global Industry Guide 2017-2021

Summary

Global Generics industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Synopsis

Essential resource for top-line data and analysis covering the global generics market. Includes market size data, textual and graphical analysis of market growth trends and leading companies.

Key Highlights
  • For the purposes of this profile, a generic is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and all branded generics are included. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included.
    The market value is evaluated at ex-factory prices.
    Market volume is quantified here as the percentage of the total ethical pharmaceutical market volume in a country or region which is accounted for by generic drugs. It is therefore a generics penetration rate measure, not an absolute measure of market volume.
    Regional volumes are calculated as weighted averages of countries which make up the region in question where volume data exists.
    Please note that any volumes of "1" (one) or 100% are due to rounding as MarketLine does not believe that generics will ever fully represent 100% of the medicinal market in any country or region.
    All currency conversions were calculated at constant average annual 2016 exchange rates.
  • The global generics market had total revenues of $311.1bn in 2016, representing a compound annual growth rate (CAGR) of 9.5% between 2012 and 2016.
  • Market consumption volume increased with a CAGR of 2.2% between 2012 and 2016, to reach a total of 82.1% of total pharma volume in 2016.
  • Strong growth will continue in the emerging markets but worldwide there will be a deceleration.
Scope
  • Save time carrying out entry-level research by identifying the size, growth, and leading players in the global generics market
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the global generics market
  • Leading company profiles reveal details of key generics market players’ global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the global generics market with five year forecasts by both value and volume
Reasons to buy
  • What was the size of the global generics market by value in 2016?
  • What will be the size of the global generics market in 2021?
  • What factors are affecting the strength of competition in the global generics market?
  • How has the market performed over the last five years?
  • How large is the global generics market in relation to its regional counterparts?
READ MORE
Note: Product cover images may vary from those shown
2 of 3
EXECUTIVE SUMMARY
Market value
Market value forecast
Market volume
Market volume forecast
Geography segmentation
Introduction
What is this report about?
Who is the target reader?
How to use this report
Definitions
Global Generics
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Generics in Asia-Pacific
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Generics in Europe
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Generics in France
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Generics in Germany
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Generics in Italy
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Generics in Japan
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Generics in Australia
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Generics in Canada
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Generics in China
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Generics in The Netherlands
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Generics in Spain
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Generics in The United Kingdom
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Generics in The United States
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Company Profiles
Leading Companies
Appendix
Methodology
About the Author

List of Tables
Table 1: Global generics market value: $ billion, 2012-16
Table 2: Global generics market volume: % of total pharma volume, 2012-16
Table 3: Global generics market geography segmentation: $ billion, 2016
Table 4: Global generics market value forecast: $ billion, 2016-21
Table 5: Global generics market volume forecast: % of total pharma volume, 2016-21
Table 6: Asia-Pacific generics market value: $ billion, 2012-16
Table 7: Asia-Pacific generics market volume: % of total pharma volume, 2012-16
Table 8: Asia-Pacific generics market geography segmentation: $ billion, 2016
Table 9: Asia-Pacific generics market value forecast: $ billion, 2016-21
Table 10: Asia-Pacific generics market volume forecast: % of total pharma volume, 2016-21
Table 11: Europe generics market value: $ billion, 2012-16
Table 12: Europe generics market volume: % of total pharma volume, 2012-16
Table 13: Europe generics market geography segmentation: $ billion, 2016
Table 14: Europe generics market value forecast: $ billion, 2016-21
Table 15: Europe generics market volume forecast: % of total pharma volume, 2016-21
Table 16: France generics market value: $ million, 2012-16
Table 17: France generics market volume: % of total pharma volume, 2012-16
Table 18: France generics market geography segmentation: $ million, 2016
Table 19: France generics market value forecast: $ million, 2016-21
Table 20: France generics market volume forecast: % of total pharma volume, 2016-21
Table 21: France size of population (million), 2012-16
Table 22: France gdp (constant 2005 prices, $ billion), 2012-16
Table 23: France gdp (current prices, $ billion), 2012-16
Table 24: France inflation, 2012-16
Table 25: France consumer price index (absolute), 2012-16
Table 26: France exchange rate, 2012-16
Table 27: Germany generics market value: $ million, 2012-16
Table 28: Germany generics market volume: % of total pharma volume, 2012-16
Table 29: Germany generics market geography segmentation: $ million, 2016
Table 30: Germany generics market value forecast: $ million, 2016-21
Table 31: Germany generics market volume forecast: % of total pharma volume, 2016-21
Table 32: Germany size of population (million), 2012-16
Table 33: Germany gdp (constant 2005 prices, $ billion), 2012-16
Table 34: Germany gdp (current prices, $ billion), 2012-16
Table 35: Germany inflation, 2012-16
Table 36: Germany consumer price index (absolute), 2012-16
Table 37: Germany exchange rate, 2012-16
Table 38: Italy generics market value: $ million, 2012-16
Table 39: Italy generics market volume: % of total pharma volume, 2012-16
Table 40: Italy generics market geography segmentation: $ million, 2016
Table 41: Italy generics market value forecast: $ million, 2016-21
Table 42: Italy generics market volume forecast: % of total pharma volume, 2016-21
Table 43: Italy size of population (million), 2012-16
Table 44: Italy gdp (constant 2005 prices, $ billion), 2012-16
Table 45: Italy gdp (current prices, $ billion), 2012-16
Table 46: Italy inflation, 2012-16
Table 47: Italy consumer price index (absolute), 2012-16
Table 48: Italy exchange rate, 2012-16
Table 49: Japan generics market value: $ billion, 2012-16
Table 50: Japan generics market volume: % of total pharma volume, 2012-16
Table 51: Japan generics market geography segmentation: $ billion, 2016
Table 52: Japan generics market value forecast: $ billion, 2016-21
Table 53: Japan generics market volume forecast: % of total pharma volume, 2016-21
Table 54: Japan size of population (million), 2012-16
Table 55: Japan gdp (constant 2005 prices, $ billion), 2012-16
Table 56: Japan gdp (current prices, $ billion), 2012-16
Table 57: Japan inflation, 2012-16
Table 58: Japan consumer price index (absolute), 2012-16
Table 59: Japan exchange rate, 2012-16
Table 60: Australia generics market value: $ million, 2012-16
Table 61: Australia generics market volume: % of total pharma volume, 2012-16
Table 62: Australia generics market geography segmentation: $ million, 2016
Table 63: Australia generics market value forecast: $ million, 2016-21
Table 64: Australia generics market volume forecast: % of total pharma volume, 2016-21
Table 65: Australia size of population (million), 2012-16
Table 66: Australia gdp (constant 2005 prices, $ billion), 2012-16
Table 67: Australia gdp (current prices, $ billion), 2012-16
Table 68: Australia inflation, 2012-16
Table 69: Australia consumer price index (absolute), 2012-16
Table 70: Australia exchange rate, 2012-16
Table 71: Canada generics market value: $ million, 2012-16
Table 72: Canada generics market volume: % of total pharma volume, 2012-16
Table 73: Canada generics market geography segmentation: $ million, 2016
Table 74: Canada generics market value forecast: $ million, 2016-21
Table 75: Canada generics market volume forecast: % of total pharma volume, 2016-21

List of Figures
Figure 1: Global generics market value: $ billion, 2012-16
Figure 2: Global generics market volume: % of total pharma volume, 2012-16
Figure 3: Global generics market geography segmentation: % share, by value, 2016
Figure 4: Global generics market value forecast: $ billion, 2016-21
Figure 5: Global generics market volume forecast: % of total pharma volume, 2016-21
Figure 6: Forces driving competition in the global generics market, 2016
Figure 7: Drivers of buyer power in the global generics market, 2016
Figure 8: Drivers of supplier power in the global generics market, 2016
Figure 9: Factors influencing the likelihood of new entrants in the global generics market, 2016
Figure 10: Factors influencing the threat of substitutes in the global generics market, 2016
Figure 11: Drivers of degree of rivalry in the global generics market, 2016
Figure 12: Asia-Pacific generics market value: $ billion, 2012-16
Figure 13: Asia-Pacific generics market volume: % of total pharma volume, 2012-16
Figure 14: Asia-Pacific generics market geography segmentation: % share, by value, 2016
Figure 15: Asia-Pacific generics market value forecast: $ billion, 2016-21
Figure 16: Asia-Pacific generics market volume forecast: % of total pharma volume, 2016-21
Figure 17: Forces driving competition in the generics market in Asia-Pacific, 2016
Figure 18: Drivers of buyer power in the generics market in Asia-Pacific, 2016
Figure 19: Drivers of supplier power in the generics market in Asia-Pacific, 2016
Figure 20: Factors influencing the likelihood of new entrants in the generics market in Asia-Pacific, 2016
Figure 21: Factors influencing the threat of substitutes in the generics market in Asia-Pacific, 2016
Figure 22: Drivers of degree of rivalry in the generics market in Asia-Pacific, 2016
Figure 23: Europe generics market value: $ billion, 2012-16
Figure 24: Europe generics market volume: % of total pharma volume, 2012-16
Figure 25: Europe generics market geography segmentation: % share, by value, 2016
Figure 26: Europe generics market value forecast: $ billion, 2016-21
Figure 27: Europe generics market volume forecast: % of total pharma volume, 2016-21
Figure 28: Forces driving competition in the generics market in Europe, 2016
Figure 29: Drivers of buyer power in the generics market in Europe, 2016
Figure 30: Drivers of supplier power in the generics market in Europe, 2016
Figure 31: Factors influencing the likelihood of new entrants in the generics market in Europe, 2016
Figure 32: Factors influencing the threat of substitutes in the generics market in Europe, 2016
Figure 33: Drivers of degree of rivalry in the generics market in Europe, 2016
Figure 34: France generics market value: $ million, 2012-16
Figure 35: France generics market volume: % of total pharma volume, 2012-16
Figure 36: France generics market geography segmentation: % share, by value, 2016
Figure 37: France generics market value forecast: $ million, 2016-21
Figure 38: France generics market volume forecast: % of total pharma volume, 2016-21
Figure 39: Forces driving competition in the generics market in France, 2016
Figure 40: Drivers of buyer power in the generics market in France, 2016
Figure 41: Drivers of supplier power in the generics market in France, 2016
Figure 42: Factors influencing the likelihood of new entrants in the generics market in France, 2016
Figure 43: Factors influencing the threat of substitutes in the generics market in France, 2016
Figure 44: Drivers of degree of rivalry in the generics market in France, 2016
Figure 45: Germany generics market value: $ million, 2012-16
Figure 46: Germany generics market volume: % of total pharma volume, 2012-16
Figure 47: Germany generics market geography segmentation: % share, by value, 2016
Figure 48: Germany generics market value forecast: $ million, 2016-21
Figure 49: Germany generics market volume forecast: % of total pharma volume, 2016-21
Figure 50: Forces driving competition in the generics market in Germany, 2016
Figure 51: Drivers of buyer power in the generics market in Germany, 2016
Figure 52: Drivers of supplier power in the generics market in Germany, 2016
Figure 53: Factors influencing the likelihood of new entrants in the generics market in Germany, 2016
Figure 54: Factors influencing the threat of substitutes in the generics market in Germany, 2016
Figure 55: Drivers of degree of rivalry in the generics market in Germany, 2016
Figure 56: Italy generics market value: $ million, 2012-16
Figure 57: Italy generics market volume: % of total pharma volume, 2012-16
Figure 58: Italy generics market geography segmentation: % share, by value, 2016
Figure 59: Italy generics market value forecast: $ million, 2016-21
Figure 60: Italy generics market volume forecast: % of total pharma volume, 2016-21
Figure 61: Forces driving competition in the generics market in Italy, 2016
Figure 62: Drivers of buyer power in the generics market in Italy, 2016
Figure 63: Drivers of supplier power in the generics market in Italy, 2016
Figure 64: Factors influencing the likelihood of new entrants in the generics market in Italy, 2016
Figure 65: Factors influencing the threat of substitutes in the generics market in Italy, 2016
Figure 66: Drivers of degree of rivalry in the generics market in Italy, 2016
Figure 67: Japan generics market value: $ billion, 2012-16
Figure 68: Japan generics market volume: % of total pharma volume, 2012-16
Figure 69: Japan generics market geography segmentation: % share, by value, 2016
Figure 70: Japan generics market value forecast: $ billion, 2016-21
Figure 71: Japan generics market volume forecast: % of total pharma volume, 2016-21
Figure 72: Forces driving competition in the generics market in Japan, 2016
Figure 73: Drivers of buyer power in the generics market in Japan, 2016
Figure 74: Drivers of supplier power in the generics market in Japan, 2016
Figure 75: Factors influencing the likelihood of new entrants in the generics market in Japan,
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll